Although the European Medicines Agency (EMA) recently approved a recombinant FVIIa (rFVIIa) for the treatment of acute bleeding in postpartum hemorrhage (PPH), its use is associated with risks of ...

Postpartum hemorrhage due to uterine atony is the primary direct cause of maternal mortality globally. Management strategies in developed countries involve crystalloid fluid replacement ...

A new study published in the journal of BMC Pregnancy and Childbirth revealed that postpartum hemorrhage (PPH) is not well ...

Postpartum cerebral angiopathy ... and she had no family history of subarachnoid hemorrhage (SAH). 8 years before her current presentation, she had an entirely uncomplicated pregnancy and delivery ...

“No woman should fear for her life when giving birth. Effective solutions to tackle postpartum bleeding need to be available and accessible so that all women can experience a safe birth and a ...

At a nondescript office nestled on Edison Way in North Fair Oaks, a small company is hard at work developing a medical device that could transform the way physicians treat postpartum hemorrhage ...

France: A recent case published in BMC Nephrology highlights the possible role of tranexamic acid (TXA) in precipitating ...